InflaRX
Würzburg, Germany · Founded 2007
- Headquarters
- Würzburg
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- inflarx.de
About
InflaRx is a clinical-stage biopharmaceutical company founded in December 2007 in Jena, Germany, pioneering anti-inflammatory therapeutics that target the complement system, particularly C5a and its receptor C5aR. Its lead product, GOHIBIC (vilobelimab), received FDA Emergency Use Authorization for severe COVID-19 and EU marketing authorization for ARDS. InflaRx completed its Nasdaq IPO in November 2017 and maintains offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, Michigan, USA.
Summary
InflaRX is a Biotech company based in Würzburg, Germany, founded in 2007.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/inflarx"><img src="https://indexed.vc/api/badge/company/inflarx" alt="InflaRX on Indexed.vc" width="260" height="76" /></a>